Annemarieke Bartels‐Rutten

Author

Also Known As

A Bartels-Rutten, A. Bartels-Rutten, Annemarieke Bartels-Rutten, Annemarieke Bartels‐Rutten, Bartels-Rutten, Annemarieke, J. J. Bergman, Sandra Bakker

Publications

700

Citations

H-Index

Concepts

All Affiliations

The Netherlands Cancer Institute Oncode Institute University of Amsterdam Amsterdam University Medical Centers University Medical Center Utrecht

About

Annemarieke Bartels‐Rutten is an author at The Netherlands Cancer Institute specializing in oncology, health sciences, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	5	5	131
2	Medicine	4	4	118
3	Engineering	1	1	12
4	Emergency Medicine	1	1	11
5	Gastroenterology	1	1	15

Annemarieke Bartels‐Rutten

Publications

588

Citations

H-Index

Page 1

	Year	Citations
Treatment and Long-Term Clinical Outcomes of Incidental Pulmonary Embolism in Patients With Cancer: An International Prospective Cohort Study Noémie Kraaijpoel, Suzanne M. Bleker, Guy Meyer, Journal of Clinical Oncology	2019	113
Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial Y.L. Verschoor, Joris van de Haar, José G. van den Berg, Nature Medicine	2024	93
Preoperative Prediction of Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients With Esophageal Cancer Using 18F-FDG PET/CT and DW-MRI: A Prospective Multicenter Study Alicia S. Borggreve, Lucas Goense, Peter S.N. van Rossum, International Journal of Radiation OncologyBiologyPhysics Neoadjuvant ChemoradiotherapyPreoperative PredictionMedical ImagingRadiation TherapyMedicine	2020	80
Artificial Intelligence Tool for Detection and Worklist Prioritization Reduces Time to Diagnosis of Incidental Pulmonary Embolism at CT Laurens Topff, Erik Ranschaert, Annemarieke Bartels‐Rutten, Radiology Cardiothoracic Imaging	2023	69
DW-MRI and DCE-MRI are of complementary value in predicting pathologic response to neoadjuvant chemoradiotherapy for esophageal cancer S.E. Heethuis, Lucas Goense, Peter S.N. van Rossum, Acta Oncologica	2018	60
Yield of Screening for COVID-19 in Asymptomatic Patients Before Elective or Emergency Surgery Using Chest CT and RT-PCR (SCOUT) Carl A. J. Puylaert, Jochem C G Scheijmans, Alexander B.J. Borgstein, Annals of Surgery	2020	51
Diagnostic performance of MRI for assessment of response to neoadjuvant chemoradiotherapy in oesophageal cancer Sophie E. Vollenbrock, Francine E.M. Voncken, Jolanda M. van Dieren, British journal of surgery	2019	43
Gross Tumor Delineation in Esophageal Cancer on MRI Compared With 18F-FDG-PET/CT Sophie E. Vollenbrock, Marlies E. Nowee, Francine E.M. Voncken, Advances in Radiation Oncology	2019	17
Neoadjuvant atezolizumab plus docetaxel/oxaliplatin/capecitabine in non-metastatic gastric and gastroesophageal junction adenocarcinoma: The PANDA trial. Y.L. Verschoor, Liudmila L. Kodach, José van den Berg, Journal of Clinical Oncology Surgical OncologyEsophageal CancerImmunologyGastroenterologyPathology	2022	15
A Novel Liquid Fiducial Marker in Esophageal Cancer Image Guided Radiation Therapy: Technical Feasibility and Visibility on Imaging Mélanie Machiels, Francine E.M. Voncken, Peng Jin, Practical Radiation Oncology EngineeringOncologic ImagingMedical ImagingRadiation TherapyEsophageal Cancer	2019	12

Page 1